JAK inhibitors and infections risk: focus on herpes zoster

Currently, there is a growing interest in Janus kinase (JAK) intracellular signalling since targeted inhibitors against these pathways are proving effective in the treatment of a range of immune-mediated diseases, such as rheumatoid arthritis (RA), psoriasis, psoriatic arthritis (PsA), inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Sunzini, Flavia, McInnes, Iain, Siebert, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
When Rheumatology and Infectious Disease Come Together
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328488/
https://www.ncbi.nlm.nih.gov/pubmed/32655703
http://dx.doi.org/10.1177/1759720X20936059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328488/
https://www.ncbi.nlm.nih.gov/pubmed/32655703
http://dx.doi.org/10.1177/1759720X20936059

Ejemplares similares